Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Dec 31;10(12):e038489.
doi: 10.1136/bmjopen-2020-038489.

Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis

Affiliations
Meta-Analysis

Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis

Yaqiong Zhou et al. BMJ Open. .

Abstract

Objectives: Accurate subtype classification in primary aldosteronism (PA) is critical in assessing the optimal treatment options. This study aimed to evaluate the diagnostic accuracy of adrenal imaging for unilateral PA classification.

Methods: Systematic searches of PubMed, EMBASE and the Cochrane databases were performed from 1 January 2000 to 1 February 2020, for all studies that used CT or MRI in determining unilateral PA and validated the results against invasive adrenal vein sampling (AVS). Summary diagnostic accuracies were assessed using a bivariate random-effects model. Subgroup analyses, meta-regression and sensitivity analysis were performed to explore the possible sources of heterogeneity.

Result: A total of 25 studies, involving a total of 4669 subjects, were identified. The overall analysis revealed a pooled sensitivity of 68% (95% CI: 61% to 74%) and specificity of 57% (95% CI 50% to 65%) for CT/MRI in identifying unilateral PA. Sensitivity was higher in the contrast-enhanced (CT) group versus the traditional CT group (77% (95% CI 66% to 85%) vs 58% (95% CI 50% to 66%). Subgroup analysis stratified by screening test for PA showed that the sensitivity of the aldosterone-to-renin ratio (ARR) group was higher than that of the non-ARR group (78% (95% CI 69% to 84%) vs 66% (95% CI 58% to 72%)). The diagnostic accuracy of PA patients aged ≤40 years was reported in four studies, and the overall sensitivity was 71%, with 79% specificity. Meta-regression revealed a significant impact of sample size on sensitivity and of age and study quality on specificity.

Conclusion: CT/MRI is not a reliable alternative to invasive AVS without excellent sensitivity or specificity for correctly identifying unilateral PA. Even in young patients (≤40 years), 21% of patients would have undergone unnecessary adrenalectomy based on imaging results alone.

Keywords: cardiology; endocrine tumours; hypertension.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of the review process. AVS, adrenal vein sampling.
Figure 2
Figure 2
Assessment of methodological quality of included studies using the QUADAS-2 Criteria. Stacked bars represent the proportion of studies with a high (red), or unclear (yellow) or low (green) risk of bias and applicability concerns. QUADAS-2, Quality Assessment of Diagnostic Accuracy Studies-2 criteria.
Figure 3
Figure 3
Forest plots of sensitivity and specificity of adrenal imaging compared with AVS. Horizontal lines are the 95% CIs. AVS, adrenal vein sampling.
Figure 4
Figure 4
Hierarchical SROC plot showing average sensitivity and specificity estimate of the study results with 95% confidence region. The 95% prediction region represents the confidence region for a forecast of the true sensitivity (SENS) and specificity (SPEC) in a future study. AUC, area under the curve; SROC, summary receiver operating characteristic.

References

    1. Monticone S, Burrello J, Tizzani D, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol 2017;69:1811–20. 10.1016/j.jacc.2017.01.052 - DOI - PubMed
    1. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008;168:80–5. 10.1001/archinternmed.2007.33 - DOI - PubMed
    1. Pillai PR, Griffith M, Schwarcz MD, et al. Primary aldosteronism: cardiovascular risk, diagnosis, and management. Cardiol Rev 2020;28:84–91. 10.1097/CRD.0000000000000281 - DOI - PubMed
    1. Hundemer GL, Curhan GC, Yozamp N, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 2018;6:51–9. 10.1016/S2213-8587(17)30367-4 - DOI - PMC - PubMed
    1. Funder JW. Primary aldosteronism: where are we now? Where to from here? Horm Metab Res 2020;52:459–66. 10.1055/a-1120-8623 - DOI - PubMed

Publication types

LinkOut - more resources